More recently, the insomnia side-effect was found to be associated with genetic variations in the μ-opioid receptor (OPRM1) gene (Wang et al., 2012), which indicates that susceptible polymorphisms may also affect sleep control among patients on methadone. The gene discussed is OPRM1; the disease is insomnia.